Back4D Molecular Therapeutics Overview
4D Molecular Therapeutics Inc

4D Molecular Therapeutics Target Price

See 4D Molecular Therapeutics's analyst price targets ($33) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.75

Average Target Price

$33.00207% upside

1 analysts in the last 4 months

High: $33 | Low: $33

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-08Goldman Sachs$33207% upsideOpen
2025-11-11BarclaysGena Wang$33207% upsideOpen
2025-10-31Leerink PartnersMani Foroohar$1758.1% upsideOpen
2025-10-21RBC CapitalLisa Walter$26141.9% upsideOpen
2025-01-11Morgan StanleyJudah Frommer$644.2% downsideOpen
2024-09-19BMO CapitalKostas Biliouris$40272.1% upsideOpen
2024-09-19Loop Capital MarketsGeulah Livshits$39262.8% upsideOpen
2024-09-19H.C. WainwrightMatthew Caufield$36234.9% upsideOpen
2024-04-15RBC CapitalLisa Walter$40272.1% upsideOpen
2024-04-15BarclaysGena Wang$45318.6% upsideOpen
2024-04-01JefferiesNalin Tejavibulya$58439.5% upsideOpen
2024-03-28BMO CapitalKostas Biliouris$63486% upsideOpen
2024-02-06BMO CapitalKostas Biliouris$70551.2% upsideOpen
2023-07-05Chardan CapitalGeulah Livshits$30179.1% upsideOpen
2022-11-18H.C. Wainwright$36234.9% upsideOpen
2022-04-05Evercore ISIJosh Schimmer$40272.1% upsideOpen

4D Molecular Therapeutics (FDMT) FAQ

The latest target price for FDMT is $33. Investors often review this figure alongside 4D Molecular Therapeutics's historical trend and sector peers before judging valuation or financial health.

4D Molecular Therapeutics trades near $10.75 while the consensus target sits at $33 (207.0% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting FDMT's target price ($33), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 4D Molecular Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.